A share price of Exelixis Inc [EXEL] is currently trading at $34.50, up 0.85%. An important factor to consider is whether the stock is rising or falling in short-term value. The EXEL shares have gain 3.60% over the last week, with a monthly amount drifted -3.69%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Exelixis Inc [NASDAQ: EXEL] stock has seen the most recent analyst activity on December 20, 2024, when BMO Capital Markets downgraded its rating to a Market Perform and also boosted its price target to $40 from $36. Previously, BofA Securities downgraded its rating to Neutral on December 17, 2024, and elevated its price target to $39. On October 16, 2024, RBC Capital Mkts reiterated its Outperform rating and revised its price target to $34 on the stock. UBS started tracking the stock assigning a Neutral rating and suggested a price target of $30 on September 19, 2024. Barclays downgraded its rating to a Equal Weight but $25 remained the price target by the analyst firm on April 11, 2024. BTIG Research started tracking with a Buy rating for this stock on December 19, 2023, and assigned it a price target of $27. In a note dated December 15, 2023, Citigroup initiated an Buy rating and provided a target price of $31 on this stock.
Exelixis Inc experienced fluctuations in its stock price throughout the past year between $19.20 and $36.97. Currently, Wall Street analysts expect the stock to reach $31.63 within the next 12 months. Exelixis Inc [NASDAQ: EXEL] shares were valued at $34.50 at the most recent close of the market. An investor can expect a potential drop of -8.32% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
Trailing Twelve Months sales for Exelixis Inc [NASDAQ:EXEL] were 2.08B which represents 14.33% growth. Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at 0.25%, Pretax Profit Margin comes in at 0.29%, and Net Profit Margin reading is 0.22%. To continue investigating profitability, this company’s Return on Assets is posted at 0.16, Equity is 0.21 and Total Capital is 0.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 34.10 points at the first support level, and at 33.69 for the second support level. However, for the 1st resistance point, the stock is sitting at 34.73, and for the 2nd resistance point, it is at 34.95.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Exelixis Inc [NASDAQ:EXEL] is 3.93. On the other hand, the Quick Ratio is 3.88, and the Cash Ratio is 0.66. Considering the valuation of this stock, the price to sales ratio is 4.73, the price to book ratio is 4.33 and price to earnings (TTM) ratio is 21.99.
Transactions by insiders
Recent insider trading involved Hessekiel Jeffrey, EVP & General Counsel, that happened on Nov 29 ’24 when 60000.0 shares were sold. Officer, JEFFREY HESSEKIEL completed a deal on Nov 29 ’24 to buy 60000.0 shares. Meanwhile, EVP, Commercial Haley Patrick J. sold 10000.0 shares on Nov 22 ’24.